NDC11 61354011702
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 61354-0117-02 | 61354-0117 |
| 61354-0117-2 | 61354-0117 |
| 61354-117-02 | 61354-117 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 61354-117-02 61354-117 61354011702 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.